ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

IPH Innate Pharma

1.872
-0.006 (-0.32%)
14 Mar 2025 - Closed
Delayed by 15 minutes

Innate Pharma Financial Summary

The current IPH market cap is 595.62M. The company's latest EPS is EUR -0.0238 and P/E is -78.57.

Year End 31 December 2023 20192020202120222023
EUR (€)EUR (€)EUR (€)EUR (€)EUR (€)
Total Revenue 85.81M71.32M26.5M57.89M61.64M
Operating Income -27.05M-62.08M-54.98M-57.53M-12.66M
Net Income -20.76M-63.98M-52.81M-58.1M-7.57M
Year End 31 December 2023 20192020202120222023
EUR (€)EUR (€)EUR (€)EUR (€)EUR (€)
Total Assets 401.36M307.42M267.5M207.86M184.19M
Total Liabilities 183.95M151.45M160.06M153.71M132.29M
Total Equity 217.42M155.98M107.44M54.15M51.9M

Cash Flow

Year End 31 December 2023 20192020202120222023
EUR (€)EUR (€)EUR (€)EUR (€)EUR (€)
Operating 34.92M-51.77M-58.46M-19.15M-32.56M
Investing -62.12M-13.37M-917k1.88M20.63M
Financing 77.77M-1.18M26.82M-1.83M-1.97M
Market Cap 595.62M
Price to Earnings Ratio -78.57
Price to Sales Ratio 9.65
Price to Cash Ratio 8.43
Price to Book Ratio 11.46
Dividend Yield -

Share Statistics

Shares Outstanding 318.17M
Average Volume (1 week) 118.04k
Average Volume (1 Month) 269.13k
52 Week Change -16.43%
52 Week High 2.79
52 Week Low 1.332
Spread (Intraday) 0.05 (2.81%)

Company Info

Company Name Innate Pharma
Address 117 avenue de luminy
marseille, bouches-du-rhone 13009
Website https://www.innate-pharma.com
Industry biological pds,ex diagnstics (2836)